Clinical Trial

First-in-human Trial of Home Brain Pressure Measured Using Kitea ICP Sensor, Placed During Hydrocephalus Shunt Surgery.

Study acronym: HomeICP
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients with hydrocephalus have an abnormal build-up of fluid around the brain and need a tube surgically implanted to drain that fluid. Patients and their caregivers live with the constant fear that the tube will block. Warning symptoms include irritability, headaches and vomiting. Unfortunately, there is no way of telling when fluid build-up is causing a rise in brain pressure and potentially impeding blood flow to the brain (life threatening) except for a brain scan in hospital and possibly hospitalisation. The investigators want to improve the lives of patients with hydrocephalus. They have developed a tool for parents and caregivers to monitor the pressure in the brain remotely via a sensor placed alongside the drainage tube. The device has been shown to be safe and to give reliable brain pressure readings using a large animal model (sheep). This study is a first-in-human safety study to show it is safe for patient use.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-02; most recent amendment 2026-02-11.
Status change: Recruiting → Active, Not Recruiting 2026-02-11
Status change: Not Yet Recruiting → Recruiting 2024-06-12
Trial Details
NCT Number NCT06402786
Lead Sponsor University of Auckland, New Zealand
Collaborators: Health Research Council, New Zealand, Auckland City Hospital, Kitea Health Ltd
Conditions Hydrocephalus
Enrollment 21 participants
Start Date 2024-05-27
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-13